Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malaria vaccines: are we getting closer?

Judith E Epstein1, Birgitte Giersing, Gregory Mullen

  • 1Malaria Program, Naval Medical Research Center, 503 Robert Grant Avenue, Silver Spring, MD 20910, USA. epsteinj@nmrc.navy.mil

Current Opinion in Molecular Therapeutics
|March 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Andes hantavirus: operationalising science in real time.

Lancet (London, England)·2026
Same author

Time-restricted feeding rejuvenates cerebrovascular function and preserves cognition during aging.

Research square·2026
Same author

Advancing national preparedness for the introduction of novel tuberculosis vaccines in South Africa: policy, evidence, and system readiness insights from a national workshop.

Vaccine·2026
Same author

Priority implementation research for measles-rubella microarray patches identified using the Child Health and Nutrition Research Initiative methodology.

Journal of global health·2026
Same author

Economic evaluation of combination vaccines: Enabling a more comprehensive assessment of their benefits and challenges.

Vaccine·2026
Same author

Leveraging vaccine policy and investments for the AMR challenge.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2026

Developing a highly effective malaria vaccine remains a challenge. This review examines subunit vaccines targeting antigens like circumsporozoite protein (CSP) and discusses strategies to improve efficacy beyond current candidates.

Area of Science:

  • Immunology
  • Vaccinology
  • Infectious Diseases

Background:

  • Malaria vaccine development has progressed over 40 years since irradiated sporozoite immunization was first shown to be protective.
  • The circumsporozoite protein (CSP) of Plasmodium falciparum, a key target, was cloned 25 years ago, initially raising hopes for a rapid vaccine solution.

Purpose of the Study:

  • To review recent test-of-concept studies for subunit malaria vaccines.
  • To discuss the efficacy of five key antigens (CSP, TRAP/SSP2, LSA1, MSP1, AMA1) in clinical trials.
  • To explore challenges and strategies for enhancing subunit vaccine efficacy, including comparisons with RTS,S.

Main Methods:

  • Review of recent test-of-concept studies for malaria subunit vaccines.
  • Discussion of clinical trial data (Phase IIa and IIb) for five selected antigens.

Related Experiment Videos

  • Analysis of strategies to improve vaccine efficacy and progress in whole-organism vaccine development.

    • Main Results:

    • Several subunit vaccines targeting CSP, TRAP/SSP2, LSA1, MSP1, and AMA1 have entered clinical trials.
    • Efficacy evaluations include experimental sporozoite challenge and natural infection exposure.
    • Challenges in achieving high efficacy with current subunit vaccines like RTS,S are noted.

    Conclusions:

    • Despite significant research, a highly effective malaria vaccine is still needed.
    • Strategies to improve subunit vaccine efficacy are being explored.
    • Progress continues in both subunit and whole-organism malaria vaccine development.